Enhanced HIV immune responses elicited by an apoptotic single-cycle SHIV lentivector DNA vaccine
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1481427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Deepanwita Bose und 4 weiteren Autor:innen. Beteiligte Einrichtung: New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, United States. Hauptthemen laut MEDLINE: Vaccines, DNA, Apoptosis, Simian Immunodeficiency Virus, AIDS Vaccines. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
HIV remains a major public health issue in spite of antiretroviral therapy (ART). An innovative vaccine that can induce long-lasting and effective immunity is required to curb the persistently high numbers of new infections worldwide.
Methods
A novel DNA vaccine was generated using a Simian-Human Immunodeficiency Virus (SHIV) backbone with a Zambian T/F clade C envelope and under the control of the caprine arthritis encephalitis virus long terminal repeats (LTRs) for constitutive expression. Due to the deleted integrase, this DNA vaccine “CSH-DIN-T/F Z331” performs only a single replication cycle. To increase immunogenicity, the co-expression of apoptotic genes (BAX, BAK, or caspase 8) incorporated at the end of Pol was tested to promote the release of apoptotic bodies taken up by dendritic cells leading to cross-presentation of antigen. The three vaccines (CSH-DIN-T/F Z331-BAX, CSH-DIN-T/F Z331-BAK, and CSH-DIN-T/F Z331-Cas8) were tested in vitro for expression and in vivo in BALB/cJ mice for immunogenicity.
Results
Transduced HEK293 cells co-cultured with CEMx174 confirmed the single replication cycle of the DNA vaccine and the induction of apoptosis by CSH-DIN-T/F Z331-Cas8 based on Annexin V expression. BALB/cJ mice were immunized with a combined intramuscular + intradermal/electroporation approach. Intracellular cytokine staining (ICS) from splenocytes collected 12 weeks post-prime/6 weeks post-boost demonstrated a clear superiority of caspase 8 expressing construct over the others, with higher proportions of IFN-γ-, IL-2-, and IL-21-producing CD8 T cells specific to Env, Gag, and Nef. The kinetics of immune response after various immunization schedules were also investigated.
Conclusion
This novel single-cycle DNA vaccine with apoptotic genes demonstrated an enhanced immunogenicity primarily for antigen-specific CD8+ T-cell responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, United States.
- Laboratoire Pathogénèse et Vaccination Lentivirales (PAVAL) Lab., Institut National de Recherche d'Agriculture et Environnement, Université Grenoble Alpes, Saint Martin d'Hères, France.
Zitieren
APA
Bose, D., Rogers, K. A., Shirreff, L. M., Chebloune, Y., & Villinger, F. J. (2025). Enhanced HIV immune responses elicited by an apoptotic single-cycle SHIV lentivector DNA vaccine. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1481427
Vancouver
Bose D, Rogers KA, Shirreff LM, Chebloune Y, Villinger FJ. Enhanced HIV immune responses elicited by an apoptotic single-cycle SHIV lentivector DNA vaccine. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1481427
BibTeX
@article{Bose2025,
author = {Bose, Deepanwita and Rogers, Kenneth A and Shirreff, Lisa M and Chebloune, Yahia and Villinger, Francois J},
title = {Enhanced HIV immune responses elicited by an apoptotic single-cycle SHIV lentivector DNA vaccine},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1481427}
}
EUVIMED